Can Risk Management Lead To Fewer Promotional Restrictions?
Executive Summary
Industry has been concerned that FDA's new safety oversight authorities could prompt the agency to curtail promotions in a variety of ways, from delaying the launch of advertisements to limiting who gets detailed.